| |
| Issue |
Title |
| |
| Vol 14, No 3 (2026) |
Personalization and Safety of Pharmacotherapy: Evolution of Approaches to the Treatment of Obesity and Eating Disorders |
Abstract
PDF (Rus)
|
|
D. B. Nikityuk, A. V. Pogozheva, R. N. Alyautdin |
| |
| Vol 14, No 3 (2026) |
Self-Medication with Tirzepatide for Weight Loss Resulting in Life-Threatening Conditions: A Clinical Case |
Abstract
PDF (Rus)
|
|
E. V. Dovgan, I. V. Andreeva, S. Yu. Anisimova, V. A. Andreev, V. M. Tsareva |
| |
| Vol 14, No 3 (2026) |
Tirzepatide and Semaglutide in Type 2 Diabetes Mellitus and Obesity: A Comparative Assessment of Efficacy and Safety (Review) |
Abstract
PDF (Rus)
|
|
E. M. Eliseeva, A. A. Druzhinina, A. A. Chistokhina |
| |
| Vol 14, No 3 (2026) |
Active Development Portfolio for Obesity Pharmacotherapy: An Analysis of Data from the ClinicalTrials.gov Registry |
Abstract
PDF (Rus)
|
|
R. I. Yagudina, D. S. Tsapko |
| |
| 1 - 4 of 4 Items |
|
